Mixing factor Xa and thrombin inhibiting direct oral anticoagulants produces a synergistic prolonging effect on most clotting tests-Reference-Cited by-同舟云学术

Mixing factor Xa and thrombin inhibiting direct oral anticoagulants produces a synergistic prolonging effect on most clotting tests

Published:2023-02-21 Issue:4 Volume:45 Page:603-606
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematology

Author:

Exner Thomas¹^ORCID,Ellwood Lisa¹^ORCID,Dangol Manita¹^ORCID,Favaloro Emmanuel J.²³⁴^ORCID

Affiliation:

1. Haematex Research Pty Ltd Sydney New South Wales Australia

2. Haematology Department Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital Sydney New South Wales Australia

3. School of Dentistry and Medical Sciences, Faculty of Science and Health Charles Sturt University Wagga New South Wales Australia

4. School of Medical Sciences, Faculty of Medicine and Health University of Sydney, Westmead Hospital Sydney New South Wales Australia

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.14043

Reference12 articles.

1. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

2. The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples

3. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples

4. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban;Thrombosis Journal;2024-03-01

2. An update on novel therapies for treating patients with arterial thrombosis;Expert Review of Hematology;2023-06-26

3. Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?;Seminars in Thrombosis and Hemostasis;2023-05-09